Several studies have shown that the expression of VEGF, a major proangiogenic regulator, is increased in different cell types in the epidermis and dermis of these patients [18] and that the circulating levels of VEGF are also significantly increased in patients with SSc [17, 28]. The gene discussed is VEGFA; the disease is systemic sclerosis.